Becton, Dickinson And Co. BDX

NYS: BDX | ISIN: US0758871091 7/11/2025

177,84 USD (+0,25%)

(+0,25%) 7/11/2025

Grafiek Becton, Dickinson And Co.

Grafiek Becton, Dickinson And Co.

1 dag1d 0,25%
1 week1w 0,30%
1 maand1m -8,30%
3 maanden3m -8,09%
6 maanden6m 5,89%
1 jaar1j -23,23%
5 jaar5j -26,00%

Becton, Dickinson And Co. in het nieuws

Toon enkel gratis nieuws

6 november 2025 · BD Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results · Persbericht

6 november 2025 · BD Board Increases Dividend for 54th Consecutive Year · Persbericht

4 november 2025 · BD Achieves Milestone in AGILITY Study of Revello™ Vascular Covered Stent for Treatment of Peripheral Artery Disease · Persbericht

3 november 2025 · BD Receives FDA 510(k) Clearance and CE-IVDR Certification for High-Throughput Enteric Bacterial Panels on BD COR™ System · Persbericht

22 oktober 2025 · BD Simplifies At-Home HPV Testing to Broaden Access to Cervical Cancer Screening Outside United States · Persbericht

20 oktober 2025 · BD Launches New AI-enabled Solutions to Drive Connectivity Across Healthcare Settings · Persbericht

16 oktober 2025 · BD Looks Ahead to the Next Era of Manufacturing Excellence in Broken Bow, NE and Celebrates 65 Years of Innovation in the Region · Persbericht

15 oktober 2025 · BD Announces CFO Transition Plan · Persbericht

9 oktober 2025 · BD to Announce Financial Results for its Fourth Quarter and Full Year of Fiscal 2025 · Persbericht

9 oktober 2025 · BD Reaches Major Milestone for Rotarex™ Catheter System with First Patient Enrolled in XTRACT™ Registry to Advance Real-World Evidence in Peripheral Artery Disease · Persbericht

Profiel Becton, Dickinson And Co.

Gezondheidstechnologie

Medische Specialiteiten

Productie van medische instrumenten

Website: www.bd.com

Hoofdzetel: Franklin Lakes, New Jersey Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe